Rockwell Medical Inc
XBER:RWM

Watchlist Manager
Rockwell Medical Inc Logo
Rockwell Medical Inc
XBER:RWM
Watchlist
Price: 4.2315 EUR 3.02% Market Closed
Market Cap: €397.6m

Intrinsic Value

RWM price has not been updated for more than 3 years. This may indicate that the stock has been delisted.
RWM doesn't have a meaningful market cap.

The intrinsic value for Rockwell Medical Inc (RWM) under the Base Case is 7.9493 EUR. Compared with the current market price of 4.2315 EUR, the stock appears Undervalued by 47% .

Intrinsic value calculated using DCF
€7.9493

Do our valuations actually work? See backtest results .

RWM Intrinsic Value
7.9493
Undervaluation 47%
Intrinsic Value
Price €4.2315
Monitor RWM
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €6.36
Get notified when the price drops into your buy zone
Intrinsic Value €7.95
Margin of Safety 20% €6.36
Current Price €4.23
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about RWM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is RWM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Rockwell Medical Inc.

Explain Valuation
Alternatives to RWM

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

RMTI Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one RWM stock?

The intrinsic value for Rockwell Medical Inc (RWM) under the Base Case is 7.9493 EUR.

Is RWM stock undervalued or overvalued?

Compared with the current market price of 4.2315 EUR, the stock appears Undervalued by 47% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett